0001209191-20-010848.txt : 20200219 0001209191-20-010848.hdr.sgml : 20200219 20200219205353 ACCESSION NUMBER: 0001209191-20-010848 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200218 FILED AS OF DATE: 20200219 DATE AS OF CHANGE: 20200219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yarema Kristin CENTRAL INDEX KEY: 0001803794 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36548 FILM NUMBER: 20632249 MAIL ADDRESS: STREET 1: C/O ATARA BIOTHERAPEUTICS, INC. STREET 2: 611 GATEWAY BLVD., SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001604464 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 460920988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BLVD STREET 2: SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-278-8930 MAIL ADDRESS: STREET 1: 611 GATEWAY BLVD STREET 2: SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-18 0 0001604464 Atara Biotherapeutics, Inc. ATRA 0001803794 Yarema Kristin C/O ATARA BIOTHERAPEUTICS, INC. 611 GATEWAY BLVD., SUITE 900 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Commercial Officer Employee Stock Option (Right to Buy) 14.56 2020-02-18 4 A 0 110000 0.00 A 2030-02-17 Common Stock 110000 110000 D 25% of the shares subject to the option vest on February 18, 2021 and the remaining shares vest in equal monthly installments over the following 36 months. /s/ David Tucker, Attorney-in-Fact for Kristin Yarema 2020-02-19